API Chemical Pharma...

API Chemical Pharmaceutical Intermediate Material High Purity Vandetanib 443913-73-3

API Chemical Pharmaceutical Intermediate Material High Purity Vandetanib 443913-73-3

Min.Order / FOB Price:Get Latest Price

10 Gram

Negotiable

  • Min.Order :10 Gram
  • Purity: 99%
  • Payment Terms : T/T,

Keywords

Vandetanib Pharmaceutical Intermediate Anti-cancer drug

Quick Details

  • Appearance:White Powder
  • Application:anti-cancer drug
  • PackAge:100g/ bag, 2 kg/ bag, 25kg/ carton or as required
  • ProductionCapacity:10000|Metric Ton|Month
  • Storage:Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
  • Transportation:By DHL, TNT, FedEx, HKEMS, UPS, Etc

Superiority:

 

Advantages:
 
Hubei XinRunde Chemical Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay and many other countries.

 

1. Quality.Every batch of steroid powders have tobetested by our QC(quality control) before they are allowed to sell.


2. Delivery We have stock, so we can delivery quickly at the very day when receive the payment. Within 24 hours after receiving the payment Lead time 4 or 7 days.


3. Discreet package Safelyand Professionally Disguised Package Guaranteed. For your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate.


4. Warm after-sale service Any of your question would be solved for the first as soon as possible.

 

Details:

Product Description:
Product Name: Vandetanib
CAS NO: 443913-73-3
MF: C22H24BrFN4O2
MW: 475.35
EINECS NO: 669-841-4
Description: Vandetanib is a multi-targeted tyrosine kinase inhibitor that not only acts on EGFR, VEGFR and RET tyrosine kinases in tumor cells, but also inhibits other tyrosine kinases as well as serine/threonine kinases . Vandetanib is the first approved treatment for medullary thyroid cancer for the treatment of unresectable, locally advanced or metastatic symptomatic or progressive medullary thyroid cancer.

Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of Vandetanib plus Docetaxel was assessed in patients with previously treated non-small-cell lung cancer.

Function:
Vandetanib is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. Vandetanib acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase.Vandetanib was the first drug to be approved by FDA (April 2011) for treatment of late-stage (metastatic) medullary thyroid cancer in adult patients who are ineligible for surgery.

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View